<DOC>
	<DOC>NCT00306176</DOC>
	<brief_summary>The aim of the present study is to investigate the influence of systemic exercise, rosiglitazone administration and combined pharmaceutical and lifestyle intervention on cardiovascular risk factors</brief_summary>
	<brief_title>Rosiglitazone and Exercise in Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<criteria>Type II diabetes mellitus Poor glycemic control Heart failure Renal disease Liver disease Cardiovascular event</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>rosiglitazone,exercise,cardiovascular risk factors</keyword>
</DOC>